For the Inventor, By the Inventor

Enter assignee name

Irvine, CA, United States of America

Masimo Laboratories, Inc.

USPTO Granted Patents = 33

% Expired Patents = 12.1

EPO Patents = 18

Trademarks = 5

Forward Citations = 30,141

Loading Chart...

Loading Chart...

38 inventors (with patents filed for the assignee):

Mohamed Kheir Diab (18 out of 200 patents)

Ammar Al-Ali (15 out of 619 patents)

Marcelo M Lamego (9 out of 169 patents)

4. Massi Joe E Kiani (8 out of 363 patents)

5. James M Lepper, Jr (5 out of 22 patents)

6. Walter M Weber (4 out of 132 patents)

7. Esmaiel Kiani-Azarbayjany (4 out of 51 patents)

8. Jeroen Poeze (3 out of 90 patents)

9. Greg A Olsen (3 out of 42 patents)

10. Yassir Kamel Abdul-Hafiz (3 out of 92 patents)

11. Robert A Smith (2 out of 67 patents)

12. Hung The Vo (2 out of 101 patents)

13. Jenny E Freeman (2 out of 50 patents)

14. Cristiano Dalvi (2 out of 107 patents)

15. Sean Merritt (2 out of 69 patents)

Core Competencies:

Patient Monitor

Multi-Parameter Monitor

Glucose Biosensors

Blood Oxygen Saturation

Physiological Measurement

Optical Spectroscopy

Signal Processing

Wavelength Sensors

Sepsis Monitoring

Blood Parameter Measurement

Tissue Glucose Monitoring

Active Pulse Monitoring

33 patents: Sort by Forward Citations

1. 9936917 - Patient monitor placement indicator (2018-04-10),

2. 8224411 - Noninvasive multi-parameter patient monitor (2012-07-17),

3. 8190223 - Noninvasive multi-parameter patient monitor (2012-05-29),

4. 8130105 - Noninvasive multi-parameter patient monitor (2012-03-06),

5. 8050728 - Multiple wavelength sensor drivers (2011-11-01),

6. 8029765 - SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors (2011-10-04),

7. RE42753 - Active pulse blood constituent monitoring (2011-09-26),

8. 8008088 - SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors (2011-08-30),

9. 7957780 - Physiological parameter confidence measure (2011-06-07),

10. 7941199 - Sepsis monitor (2011-05-10),

11. 7899518 - Non-invasive tissue glucose level monitoring (2011-03-01),

12. 7865222 - Method and apparatus for reducing coupling between signals in a measurement system (2011-01-04),

13. 7801581 - Optical spectroscopy pathlength measurement system (2010-09-21),

14. 7791155 - Detector shield (2010-09-07),

15. D621516 - Patient monitoring sensor (2010-08-10),

Company Overview

Masimo Laboratories, Inc. is a leading innovator in noninvasive monitoring technologies, specializing in advanced medical devices that enhance patient care. The company is renowned for its development of innovative solutions that improve the accuracy of vital sign measurements, particularly in pulse oximetry. Headquartered in Irvine, California, Masimo focuses on research and technology that address critical healthcare challenges, aiming to provide healthcare professionals with reliable tools for patient monitoring and management.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

33 Patents

#105 in Irvine, CA

#2,462 in California

#10,305 in US

#20,147 in the World

Irvine, CA, United States of America

Masimo Laboratories, Inc.

Forward Citations = 30,141

38 inventors:

Mohamed Kheir Diab (18 out of 200 patents)

Ammar Al-Ali (15 out of 619 patents)

Marcelo M Lamego (9 out of 169 patents)

4. Massi Joe E Kiani (8 out of 363 patents)

5. James M Lepper, Jr (5 out of 22 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Masimo Laboratories, Inc.. Retrieved from https://idiyas.com/company/masimo-laboratories

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…